Evidence map›Paper›PMID 21673957›Full record

ArticlePloS one2011

Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4.

Mahdi Moradi Marjaneh, Edwin P Kirk, Maximilian G Posch, Cemil Ozcelik, Felix Berger, Roland Hetzer, Robyn Otway, Tanya L Butler, Gillian M Blue, Lyn R Griffiths and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Mahdi Moradi MarjanehThe Victor Chang Cardiac Research Institute, Darlinghurst, Australia.
Edwin P Kirk
Maximilian G Posch
Cemil Ozcelik
Felix Berger
Roland Hetzer
Robyn Otway
Tanya L Butler
Gillian M Blue
Lyn R Griffiths
Diane Fatkin
Jeremy J Martinson
David S Winlaw
Michael P Feneley
Richard P Harvey
Deutsches Herzzentrum der Charité · DEUNSW Sydney · AUChildren's Hospital at Westmead · AUVictor Chang Cardiac Research Institute · AUCharité - Universitätsmedizin Berlin · DEGriffith University · AUSydney Children's Hospital · AUUniversity of Pittsburgh · USUniversity of Sydney · AU

Funding

Genetic modifiers of congenital heart diseaseR01HL068885 · NHLBI · VICTOR CHANG CARDIAC RESEARCH INSTITUTE · PI HARVEY, RICHARD P · 2001 to 2005
$494k
NHLBI NIH HHS 1R01HL68885-01NHLBI NIH HHS R01 HL068885
6 · The paper itself

Abstract

Patent foramen ovale (PFO) is associated with clinical conditions including cryptogenic stroke, migraine and varicose veins. Data from studies in humans and mouse suggest that PFO and the secundum form of atrial septal defect (ASDII) exist in an anatomical continuum of septal dysmorphogenesis with a common genetic basis. Mutations in multiple members of the evolutionarily conserved cardiac transcription factor network, including GATA4, cause or predispose to ASDII and PFO. Here, we assessed whether the most prevalent variant of the GATA4 gene, S377G, was significantly associated with PFO or ASD. Our analysis of world indigenous populations showed that GATA4 S377G was largely Caucasian-specific, and so subjects were restricted to those of Caucasian descent. To select for patients with larger PFO, we limited our analysis to those with cryptogenic stroke in which PFO was a subsequent finding. In an initial study of Australian subjects, we observed a weak association between GATA4 S377G and PFO/Stroke relative to Caucasian controls in whom ASD and PFO had been excluded (OR = 2.16; p = 0.02). However, in a follow up study of German Caucasians no association was found with either PFO or ASD. Analysis of combined Australian and German data confirmed the lack of a significant association. Thus, the common GATA4 variant S377G is likely to be relatively benign in terms of its participation in CHD and PFO/Stroke.

Indexed as

Polymorphism, GeneticAdolescentAdultAgedChildChild, PreschoolFemaleForamen Ovale, PatentGATA4 Transcription FactorHumansInfantInfant, NewbornMaleMiddle AgedMyocardiumStrokeGATA4 protein, humanGATA4 Transcription Factor

Identifiers

PMID21673957
PMCPMC3108965
OpenAlexW2081542527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.